Mary-Ann Palafox
ORCID:
0000-0001-8679-0629
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5025657236
Research Areas
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Abbott Fund
2021
Michael J. Peluso
Saki Takahashi
Jill Hakim
J. Daniel Kelly
Leonel Torres
and 41
more
Nikita S. Iyer
Keirstinne Turcios
Owen Janson
Sadie E. Munter
Cassandra Thanh
Joanna Donatelli
Christopher C. Nixon
Rebecca Hoh
Viva Tai
Emily A. Fehrman
Yanel Hernandez
Matthew A. Spinelli
Monica Gandhi
Mary-Ann Palafox
Ana Vallari
Mary A. Rodgers
John Prostko
John Hackett
Lan Trinh
Terri Wrin
Christos J. Petropoulos
Charles Y. Chiu
Philip J. Norris
Clara DiGermanio
Mars Stone
Michael P. Busch
Susanna K. Elledge
Xin Zhou
James A. Wells
Albert Shu
Theodore W. Kurtz
John E. Pak
Wesley Wu
Peter D. Burbelo
Jeffrey I. Cohen
Rachel L. Rutishauser
Jeffrey N. Martin
Steven G. Deeks
Timothy J. Henrich
Isabel Rodríguez-Barraquer
Bryan Greenhouse
Antibody detection of prior SARS-CoV-2 infection depends on severity, assay, and timing with implications for serosurveillance.
10.1126/sciadv.abh3409
article
EN
cc-by
Science Advances
2021-07-30
Michael J. Peluso
Saki Takahashi
Jill Hakim
J. Daniel Kelly
Leonel Torres
and 40
more
Nikita S. Iyer
Keirstinne Turcios
Owen Janson
Sadie E. Munter
Cassandra Thanh
Christopher C. Nixon
Rebecca Hoh
Viva Tai
Emily A. Fehrman
Yanel Hernandez
Matthew A. Spinelli
Monica Gandhi
Mary-Ann Palafox
Ana Vallari
Mary A. Rodgers
John Prostko
John Hackett
Lan Trinh
Terri Wrin
Christos J. Petroplolous
Charles Y. Chiu
Philip J. Norris
Clara DiGermanio
Mars Stone
Michael P. Busch
Susanna K. Elledge
Xin Zhou
James A. Wells
Albert Shu
Theodore W. Kurtz
John E. Pak
Wesley Wu
Peter D. Burbelo
Jeffrey I. Cohen
Rachel L. Rutishauser
Jeffrey N. Martin
Steven G. Deeks
Timothy J. Henrich
Isabel Rodríguez-Barraquer
Bryan Greenhouse
ABSTRACT Serosurveillance studies are critical for estimating SARS-CoV-2 transmission and immunity, but interpretation of results is currently limited by poorly defined variability in the performance antibody assays to detect seroreactivity over time individuals with different clinical presentations. We measured longitudinal responses plasma samples from a diverse cohort 128 160 days using 14 binding neutralization assays. For all assays, we found consistent strong effect disease severity on...
10.1101/2021.03.03.21251639
preprint
EN
cc-by
medRxiv (Cold Spring Harbor Laboratory)
2021-03-05
Coming Soon ...